Robin L. Jones

Active 1973–2025

234
Papers
26,402
Citations
90
h-index
223
i10-index

Citations

Citations per year for Robin L. Jones1926: 1 citations1976: 1 citations1977: 2 citations1978: 5 citations1979: 5 citations1980: 10 citations1981: 1 citations1982: 7 citations1983: 6 citations1984: 11 citations1985: 11 citations1986: 9 citations1987: 11 citations1988: 4 citations1989: 22 citations1990: 4 citations1991: 10 citations1992: 10 citations1993: 18 citations1994: 11 citations1995: 17 citations1996: 16 citations1997: 25 citations1998: 10 citations1999: 19 citations2000: 16 citations2001: 11 citations2002: 23 citations2003: 25 citations2004: 21 citations2005: 22 citations2006: 30 citations2007: 63 citations2008: 70 citations2009: 69 citations2010: 61 citations2011: 78 citations2012: 64 citations2013: 47 citations2014: 70 citations2015: 84 citations2016: 94 citations2017: 137 citations2018: 117 citations2019: 525 citations2020: 806 citations2021: 1,022 citations2022: 946 citations2023: 724 citations2024: 1,220 citations2025: 445 citations2026: 16 citations1927–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,746 citing papers, 21.3% of this breakdownChina: 769 citing papers, 9.4% of this breakdownUnited Kingdom: 660 citing papers, 8% of this breakdownItaly: 622 citing papers, 7.6% of this breakdownFrance: 489 citing papers, 6% of this breakdownGermany: 452 citing papers, 5.5% of this breakdownNetherlands: 324 citing papers, 4% of this breakdownCanada: 296 citing papers, 3.6% of this breakdownSpain: 291 citing papers, 3.5% of this breakdownJapan: 258 citing papers, 3.1% of this breakdownAustralia: 159 citing papers, 1.9% of this breakdownBelgium: 154 citing papers, 1.9% of this breakdown
0%21.3%Other 24.2%

Fields

  • Medicine71%
  • Biochemistry, Genetics and Molecular Biology19.8%
  • Immunology and Microbiology3%
  • Engineering0.9%
  • Neuroscience0.9%
  • Computer Science0.6%
  • Other3.8%

Topics

  • Sarcoma Diagnosis and Treatment11%
  • Gastrointestinal Tumor Research and Treatment2.7%
  • Vascular Tumors and Angiosarcomas2.7%
  • Bone Tumor Diagnosis and Treatments2.4%
  • Cardiac tumors and thrombi2.3%
  • Cancer Genomics and Diagnostics1.9%
  • Other77%

Coauthors

All papers

Open in search
  1. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 989

  2. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 1,621

  3. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 406

  4. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Gronchi, Rick L. Haas, A.B. Hassan, Stefanie Hecker‐Nolting, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Leo Kager, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, A. López Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Bruce Morland, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, Susanne Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Ruth Ladenstein, Paolo G. Casali, Silvia Stacchiotti - Annals of Oncology 2021 cited by 455

  5. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heikki Joensuu, Robin L. Jones, Christiane Jungels, Paul C. Jutte, Bernd Kasper, Akira Kawai, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Franel Le Grange, Eric Legius, Andreas Leithner, Antonio López–Pousa, Javier Martín‐Broto, Ofer Merimsky, Christina Messiou, Aisha Miah, Olivier Mir, Michael Montemurro, Carlo Morosi, Emanuela Palmerini, Maria A. Pantaleo, Raimondo Piana, Sophie Piperno‐Neumann, Peter Reichardt, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, Stefan Sleijfer, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, Annalisa Trama, Mojca Unk, Michiel A. J. van de Sande, Winette T.A. van der Graaf, Winan J. van Houdt, Thierry Frébourg, Alessandro Gronchi, Silvia Stacchiotti - Annals of Oncology 2021 cited by 563

  6. Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, W. Van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 751

  7. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 834

  8. Future Directions in the Treatment of Osteosarcoma

    Authors: , , , , , - Cells 2021 cited by 226

  9. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 cited by 227

  10. Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 cited by 641

  11. Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 301

  12. Clinical and Molecular Spectrum of Liposarcoma

    Authors: , , , - Journal of Clinical Oncology 2017 cited by 362

  13. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 304

  14. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 306

  15. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 407

  16. Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma

    Authors: , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 139

  17. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina L. Roland, Chandrajit P. Raut, Alessandro Gronchi, on behalf of the Transatlantic Australasian RPS Working Group (TARPSWG) - Annals of Surgical Oncology 2021 cited by 243

  18. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca A. Gladdy, F. Gouin, Giovanni Grignani, J. Gutkovich, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Paul H. Huang, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Bernd Kasper, Akira Kawai, Axel Le Cesne, Franel Le Grange, Andreas Leithner, Hugh Leonard, A. Lopez Pousa, Javier Martín‐Broto, Ofer Merimsky, Priscilla Merriam, Rosalba Miceli, Olivier Mir, Michele Molinari, Michael Montemurro, Graziano Oldani, Emanuela Palmerini, Maria A. Pantaleo, S. Patel, Sophie Piperno‐Neumann, Chandrajit P. Raut, Vinod Ravi, Albiruni R. Abdul Razak, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Gonzalo Sapisochín, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, William D. Tap, Annalisa Trama, Andrew Tweddle, Winette T.A. van der Graaf, Michiel A. J. van de Sande, Winan J. van Houdt, G. van Oortmerssen, Andrew J. Wagner, Markus Wartenberg, Jayne Wood, Nadia Zaffaroni, Camilla Zimmermann, Paolo G. Casali, Angelo Paolo Dei Tos, Alessandro Gronchi - ESMO Open 2021 cited by 183

  19. Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

    Authors: , , , , , , , , , , , , , - Cancer Immunology Research 2019 cited by 163

  20. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alex J. Lazar, Robert G. Maki, Tim Mathes, Christina Messiou, Fariba Navid, Yoshihiro Nishida, Elena Palassini, Nicolas Penel, Robert Pollock, Dawid Pieper, Marlene Portnoy, Chandrajit P. Raut, Evelyne Roets, Sergio Sandrucci, Marta Sbaraglia, Silvia Stacchiotti, Katherine A. Thornton, Winette van der Graaf, Kim van der Zande, Winan J. van Houdt, Víctor M. Villalobos, Andrew J. Wagner, Eva Wardelmann, Markus Wartenberg, Sarah Watson, Aaron R. Weiss, Nikolaos Zafiropoulos - European Journal of Cancer 2020 cited by 478

  21. A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 cited by 59

  22. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 111

  23. Risk–Benefit of Dexrazoxane for Preventing Anthracycline-Related Cardiotoxicity: Re-Evaluating the European Labeling

    Authors: , , , , - Future Oncology 2018 cited by 155

  24. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 588